Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Radiation-induced brain injury: retrospective analysis of twelve pathologically proven cases.

Lee DS, Yu M, Jang HS, Kim YS, Choi BO, Kang YN, Lee YS, Kim DC, Hong YK, Jeun SS, Yoon SC.

Radiat Oncol J. 2011 Sep;29(3):147-55. doi: 10.3857/roj.2011.29.3.147. Epub 2011 Sep 30.

2.

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.

Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH.

Int J Radiat Oncol Biol Phys. 2002 May 1;53(1):58-66.

PMID:
12007942
3.
4.

Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.

Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott RM, Bishop K, Xu R, Young Poussaint T, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ.

Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):374-9.

PMID:
15667955
5.

Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas.

Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1133-41.

PMID:
10613305
6.

Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?

Nieder C, Andratschke N, Wiedenmann N, Busch R, Grosu AL, Molls M.

Strahlenther Onkol. 2004 Jul;180(7):401-7. Review.

PMID:
15241527
7.

Stereotactic radiosurgery in patients with multiple brain metastases.

Chang SD, Lee E, Sakamoto GT, Brown NP, Adler JR Jr.

Neurosurg Focus. 2000 Aug 15;9(2):e3.

PMID:
16836289
8.

Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.

Movsas B, Hanlon AL, Lanciano R, Scher RM, Weiner LM, Sigurdson ER, Hoffman JP, Eisenberg BL, Cooper HS, Provins S, Coia LR.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):43-50.

PMID:
9747818
9.

Stereotactic radiotherapy for pediatric intracranial germ cell tumors.

Zissiadis Y, Dutton S, Kieran M, Goumnerova L, Scott RM, Kooy HM, Tarbell NJ.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):108-12.

PMID:
11516859
10.

Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.

Prados MD, Larson DA, Lamborn K, McDermott MW, Sneed PK, Wara WM, Chang SM, Mack EE, Krouwer HG, Chandler KL, Warnick RE, Davis RL, Rabbitt JE, Malec M, Levin VA, Gutin PH, Phillips TL, Wilson CB.

Int J Radiat Oncol Biol Phys. 1998 Jan 1;40(1):57-63.

PMID:
9422558
11.

[Therapeutic results of the treatment brain tumors using radiosurgery and stereotactic radiotherapy].

Doleželová H, Hynková L, Pospíšil P, Kazda T, Slampa P, Coupková I, Siková I, Fardus P, Svoboda T, Garčic J, Vrzal M, Selingerová I, Horová I.

Klin Onkol. 2012;25(6):445-51. Czech.

PMID:
23301647
12.

Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results.

Narayana A, Yamada J, Berry S, Shah P, Hunt M, Gutin PH, Leibel SA.

Int J Radiat Oncol Biol Phys. 2006 Mar 1;64(3):892-7.

PMID:
16458777
13.

Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.

Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H, Chao ST.

J Neurosurg. 2011 Aug;115(2):220-9. doi: 10.3171/2011.3.JNS10495. Epub 2011 May 6.

PMID:
21548745
14.

Stereotactic radiosurgery as an adjunct to surgery and external beam radiotherapy in the treatment of patients with malignant gliomas.

Gannett D, Stea B, Lulu B, Adair T, Verdi C, Hamilton A.

Int J Radiat Oncol Biol Phys. 1995 Sep 30;33(2):461-8.

PMID:
7673034
15.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
16.

Risk factors for brain injury after carbon ion radiotherapy for skull base tumors.

Koto M, Hasegawa A, Takagi R, Fujikawa A, Morikawa T, Kishimoto R, Jingu K, Tsujii H, Kamada T.

Radiother Oncol. 2014 Apr;111(1):25-9. doi: 10.1016/j.radonc.2013.11.005. Epub 2013 Dec 11.

PMID:
24332023
17.

Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.

Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B, Ryu S.

J Neurooncol. 2009 Apr;92(2):185-91. doi: 10.1007/s11060-008-9752-9. Epub 2008 Dec 9.

PMID:
19066727
18.

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):711-22.

PMID:
11020568
19.

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.

Taghian A, Ramsay J, Allalunis-Turner J, Budach W, Gioioso D, Pardo F, Okunieff P, Bleehen N, Urtasun R, Suit H.

Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):243-9.

PMID:
8380568
20.

Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms.

Kondziolka D, Flickinger JC, Bissonette DJ, Bozik M, Lunsford LD.

Neurosurgery. 1997 Oct;41(4):776-83; discussion 783-5.

PMID:
9316038

Supplemental Content

Support Center